title: Secreted amyloid precursor protein β and secreted amyloid precursor protein α induce axon outgrowth in vitro through Egr1 signaling pathway.
abstract: BACKGROUND
  sAPPα released after α secretase cleavage of Amyloid Precursor Protein (APP) has several functions including the stimulation of neurite outgrowth although detailed morphometric analysis has not been done. Two domains involved in this function have been described and are present in sAPPβ released at the first step of amyloid peptide cleavage, raising the possibility that sAPPβ could also stimulate neurite outgrowth. We investigated the morphological effects of sAPPα and sAPPβ on primary neurons and identified a key signaling event required for the changes observed.
  
  
  RESULTS
  Final concentrations of 50 to 150 nM bacterial recombinant sAPPα or sAPPβ added to primary neuronal cultures after 1 day in vitro decreased cell adhesion 24 hours later and primary dendrite length 96 hours later. 150 nM sAPPα and sAPPβ induced a similar increase of axon outgrowth, although this increase was already significant at 100 nM sAPPα. These morphological changes induced by sAPPs were also observed when added to differentiated neurons at 5 days in vitro. Real time PCR and immunocytochemistry showed that sAPPα and sAPPβ stimulated Egr1 expression downstream of MAPK/ERK activation. Furthermore, in primary neurons from Egr1 -/- mice, sAPPs affected dendritic length but did not induce any increase of axon length.
  
  
  CONCLUSIONS
  sAPPα and sAPPβ decrease cell adhesion and increase axon elongation. These morphological changes are similar to what has been observed in response to heparan sulfate. The sAPPα/sAPPβ stimulated increase in axon growth requires Egr1 signaling. These data suggest that sAPPβ is not deleterious per se. Since sAPPβ and sAPPα are present in the embryonic brain, these two APP metabolites might play a role in axon outgrowth during development and in response to brain damage.
authors.affiliation: INSERM U894, Paris, France.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Chasseigneaux
authors.forename: Levent
authors.initials: L
authors.lastname: Dinc
authors.forename: Christiane
authors.initials: C
authors.lastname: Rose
authors.forename: Claude
authors.initials: C
authors.lastname: Chabret
authors.forename: Fanny
authors.initials: F
authors.lastname: Coulpier
authors.forename: Piotr
authors.initials: P
authors.lastname: Topilko
authors.forename: Gweltas
authors.initials: G
authors.lastname: Mauger
authors.forename: Bernadette
authors.initials: B
authors.lastname: Allinquant
mesh_terms: D016564:Amyloid beta-Protein Precursor / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001369:Axons / Q000187:drug effects / Q000378:metabolism*; D001921:Brain / Q000166:cytology; D002448:Cell Adhesion; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D051766:Early Growth Response Protein 1 / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D009474:Neurons / Q000648:ultrastructure; D015398:Signal Transduction / Q000502:physiology*
chemical_list: D016564:Amyloid beta-Protein Precursor; D051766:Early Growth Response Protein 1; C486109:Egr1 protein, mouse